Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · IEX Real-Time Price · USD
34.95
-0.65 (-1.83%)
May 17, 2024, 4:00 PM EDT - Market closed
Kymera Therapeutics Employees
Kymera Therapeutics had 187 employees on December 31, 2023. The number of employees increased by 20 or 11.98% compared to the previous year.
Employees
187
Change (1Y)
20
Growth (1Y)
11.98%
Revenue / Employee
$424,668
Profits / Employee
-$826,690
Market Cap
2.16B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 187 | 20 | 11.98% |
Dec 31, 2022 | 167 | 26 | 18.44% |
Dec 31, 2021 | 141 | 66 | 88.00% |
Dec 31, 2020 | 75 | 20 | 36.36% |
Dec 31, 2019 | 55 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
AMN Healthcare Services | 18,223 |
Amneal Pharmaceuticals | 7,700 |
Teladoc Health | 5,600 |
Integra LifeSciences Holdings | 3,946 |
Amphastar Pharmaceuticals | 1,761 |
agilon health | 1,117 |
STAAR Surgical Company | 1,115 |
ADMA Biologics | 624 |
KYMR News
- 4 days ago - Kymera Therapeutics to Present New Clinical Data from the Ongoing Phase 1 Trial of STAT3 Degrader KT-333 at EHA Annual Meeting - GlobeNewsWire
- 10 days ago - Kymera Therapeutics to Participate in Upcoming May Investor Conferences - GlobeNewsWire
- 16 days ago - Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update - GlobeNewsWire
- 23 days ago - Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2 - GlobeNewsWire
- 5 weeks ago - Kymera Therapeutics Announces Scientific Presentations at the American Association for Cancer Research 2024 Annual Meeting - GlobeNewsWire
- 2 months ago - Kymera Therapeutics Presents Preclinical Data for STAT6 and TYK2 First-In-Class, Oral Degrader Immunology Programs at the American Academy of Dermatology Annual Meeting - GlobeNewsWire
- 2 months ago - Kymera Therapeutics to Participate in Upcoming March Investor Conferences - GlobeNewsWire
- 3 months ago - Kymera Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update - GlobeNewsWire